U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07235917) titled 'A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea' on Nov. 14.
Brief Summary: This study is researching an experimental drug called mibavademab (also called "study drug"). The study is focused on patients with a condition called Functional Hypothalamic Amenorrhea (FHA). FHA is a condition where a woman stops menstruating because the brain is not sending the correct hormonal signals to the ovaries, which then are not able to cycle and ovulate properly.
The aim of the study is to see how well the study drug helps the body make the hormones necessary for ovulation and reproduction, and to assess...